Navigation Links
Adeona Reports Third Quarter 2011 Financial Results
Date:11/14/2011

ANN ARBOR, Mich., Nov. 14, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, today reported its third quarter 2011 financial results for the period ended September 30, 2011, as well as updates since the beginning of the third quarter.

Updates since the beginning of the third quarter include:

Drug Development Programs

Relapsing-Remitting Multiple Sclerosis (MS)

  • As of September 19, 2011, the 150th patient was enrolled in the clinical trial evaluating Trimesta™ (oral estriol) in women suffering from relapsing-remitting MS, per the original protocol.

  • The Lead Principal Investigator, Rhonda Voskuhl, M.D., Director, University of California, Los Angeles (UCLA) Multiple Sclerosis Program, Department of Neurology, is using grant funding to continue enrollment of an additional 10-20 patients at all 15 centers in the United States.

Cognitive Dysfunction in MS

  • On November 11, 2011, we announced that our drug candidate, Trimesta, will be utilized in a new randomized, double-blind, placebo-controlled Phase II clinical trial to evaluate its potential therapeutic effect on cognitive dysfunction in women suffering from MS, a major consequence of this disease.

  • We and the Skirball Foundation have pledged to equally support this clinical trial led by Dr. Voskuhl. The study, which focuses on cognition dysfunction in MS patients, also received financial support from the Sherak Family Fund, the Gustafson Fund, and the Diamont family.

Fibromyalgia

  • In May 2010, we announced a $17.5 million c
    '/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
2. Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting
3. Adeona Appoints Jeff Lucero Riley as Independent Chairman
4. Adeonas Planned Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease is Hot Topic at 2011 California ALS Research Summit
5. Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
6. Adeona Appoints George A. Eby to Scientific Advisory Board
7. Adeona Reports Second Quarter 2011 Financial Results
8. Adeona to Host Second Quarter 2011 Investor Conference Call
9. Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease (ALS)
10. Adeona Reports 1st Quarter 2011 Financial Results
11. Adeona to Host First Quarter 2011 Investor Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Takeda Pharmaceutical Company Limited ("Takeda") today announced ... of data from a 10-year epidemiology study to ... (U.S.) Food and Drug Administration (FDA), ... Ministry of Health, Labour, and Welfare (MHLW) / ... for pioglitazone containing medicines, including ACTOS (pioglitazone HCl). ...
(Date:8/28/2014)...  In anticipation of the upcoming MEDevice San Diego ... the first time. Industry Overview: Medtech & Life Sciences ... snapshot of San Diego,s critical involvement ... latest employment statistics to current venture capital investment trends, the ... such a vital part of the global medical device ...
(Date:8/28/2014)... 28, 2014 /PRNewswire-iReach/ -- Academy Leadership, an elite leadership ... has published a case study highlighting one ... Course . In September and October 2014, Academy Leadership ... Albuquerque , Indianapolis , Salt Lake ... - http://photos.prnewswire.com/prnh/20140828/140814 Leadership training ...
Breaking Medicine Technology:Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 4Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 6New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5
... SEATTLE, Aug. 22 Vical Incorporated (Nasdaq:,VICL) announced ... vaccine Phase 2a,clinical trials, using a plasmid DNA ... and manufactured by Vical, reinforced previously,reported Phase 1 ... was safe and well-tolerated, and was effective in ...
... - Alfacell Corporation,(Nasdaq: ACEL ) today announced ... Oncology (2007; Vol. 31, Issue 3: 663-669) reports ... cell types and tumor cell lines. The observed ... cytotoxic effect on cancer cells and,mechanistic synergism with ...
Cached Medicine Technology:Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 2Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 3Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 2Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 3
(Date:8/29/2014)... RBS Reputation Management has brought a new ... service is to help those individuals and organizations that are ... Book. The service would push down the ranking of Scam ... fully invisible on Google. , RBS Reputation Management provides ... asked how company can provide guarantee of results with the ...
(Date:8/29/2014)... August 29, 2014 Los Angeles ... offering mini implants to area patients. With this treatment, ... of long-term teeth shifting and loss of appearance. Although ... dental implants , their smaller size allows for ... and easier recovery. Once placed, mini implants can be ...
(Date:8/29/2014)... 2014 "After reading a study that said ... often, I decided that there needed to be a way ... said a concerned inventor from Sikestons, Mo. , The Stand ... It builds endurance and keeps the user from sitting too ... use and producible in design variations, it's ideal for anyone ...
(Date:8/29/2014)... India (PRWEB) August 29, 2014 Ethane ... has recently launched a new service named HTML web ... research based service. Before tailoring the service, Ethane Web ... by other companies. The company has done its best ... impeccable and able to deliver outstanding results to clients. ...
(Date:8/29/2014)... and basic life support (BLS) videos available on ... health guidelines, according to a new study published ... for the Australasian College for Emergency Medicine (ACEM). ... cardiac arrest are known to improve survival for,victims. ... put together the study, which reviewed educational videos ...
Breaking Medicine News(10 mins):Health News:RBS Reputation Management Announces a New Online Reputation Management Service 2Health News:Dental Implants Dentist, Kevin Sands DDS, Is Now Offering Mini Implants 2Health News:Ethane Web Technologies Launches a New Web Design Service 2
... UC Irvine Medical Center recently received a Silver Medal of ... for its role in supporting organ and tissue donation. ... the highest-performing 12-month period between Oct. 1, 2008, and March ... commended in the seven-county Greater Los Angeles area served by ...
... THURSDAY, Dec. 2 (HealthDay News) -- The suicide rate among ... than among civilian women, a new study has found. ... between 2004 and 2007. In the 18-to-34 age group, there ... 33,257,362 nonveterans. That suicide rate amounted to one out ...
... arthritis drug reduces the incidence of non-melanoma skin cancers ... to a study published this week in the ... COX-2 inhibitor celecoxib (brand name Celebrex), which is currently ... acute pain in adults led to a 62 percent ...
... a lawyer, a politician, a professional athlete, an environmentalist or ... some researchers. Still others say the driving force is our ... But a new child-development theory bridges those two models, says ... Holden,s theory holds that the way a child turns out ...
... early in life led to an accumulation of abdominal fat and ... according to new research. Animals exposed to the fine-particulate air ... and higher blood sugar levels than did animals eating the same ... the polluted air for six hours a day, five days a ...
... From microscopy to computer tomography (CT) scans, imaging ... research, but obtaining high-quality images often requires advanced ... a project which launches its preparatory phase today, ... access to state-of-the-art imaging technologies at all levels ...
Cached Medicine News:Health News:UC Irvine Medical Center is recognized for its commitment to organ donation 2Health News:Female Vets Much More Likely to Commit Suicide, Study Finds 2Health News:Widely used arthritis pill protects against skin cancer 2Health News:Widely used arthritis pill protects against skin cancer 3Health News:Beyond nature vs. nurture: Parental guidance boosts child's strengths, shapes development 2Health News:Beyond nature vs. nurture: Parental guidance boosts child's strengths, shapes development 3Health News:Beyond nature vs. nurture: Parental guidance boosts child's strengths, shapes development 4Health News:Polluted air increases obesity risk in young animals 2Health News:Polluted air increases obesity risk in young animals 3Health News:Better imaging from bench to bedside 2
... fast, precise patternless edge for a perfect ... ALE-X1. The latest advance in lens processing ... and functions. High-speed processing, a diamond luster ... precise three-dimensional frame tracing via the automated ...
... mapping software system enhances clinical evaluations with ... corneal maps. The system offers an enlarged ... refractive and keratometric data, and peripheral keratometric ... subclinical keratoconus as well as pre and ...
... Ergonomic, computer-integrated, flexibility, combined with the ... contemporary styling, make the new Topcon ... highly competitive 21st Century practice environments: ... lane fits comfortably in an 8' ...
... Topcon combines the benefits of IMAGEnet Lite, ... a Compaq PC with the Topcon TRC-NW6 ... use color fundus screening package. The system ... software with Topcons Non-Mydriatic retinal camera allowing ...
Medicine Products: